{"id":"https://openalex.org/W2168653455","doi":"https://doi.org/10.1023/a:1008306616994","title":"Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: A phase II trial","display_name":"Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: A phase II trial","publication_year":2001,"publication_date":"2001-01-01","ids":{"openalex":"https://openalex.org/W2168653455","doi":"https://doi.org/10.1023/a:1008306616994","mag":"2168653455","pmid":"https://pubmed.ncbi.nlm.nih.gov/11249055"},"language":"en","primary_location":{"id":"doi:10.1023/a:1008306616994","doi":"https://doi.org/10.1023/a:1008306616994","is_oa":true,"landing_page_url":"https://doi.org/10.1023/a:1008306616994","pdf_url":"https://doi.org/10.1023/a:1008306616994","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1023/a:1008306616994","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004910627","display_name":"C. Harris Spiridonidis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094388","display_name":"Columbus Oncology and Hematology Associates","ror":"https://ror.org/00qj38h30","country_code":"US","type":"other","lineage":["https://openalex.org/I4210094388"]},{"id":"https://openalex.org/I4210150882","display_name":"Hematology Oncology Consultants","ror":"https://ror.org/04qqn5v91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210150882"]},{"id":"https://openalex.org/I4210165485","display_name":"Columbus Community Clinical Oncology Program","ror":"https://ror.org/05rvv6a54","country_code":"US","type":"other","lineage":["https://openalex.org/I4210165485"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C.H. Spiridonidis","raw_affiliation_strings":["Hematology Oncology Consultants Incorporated, Columbus, Ohio 43215, USA. hspiridoni@aol.com","Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","^Columbus Oncology Associates, Columbus,","Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated, Columbus, Ohio 43215, USA. hspiridoni@aol.com","institution_ids":["https://openalex.org/I4210150882"]},{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","institution_ids":["https://openalex.org/I4210150882","https://openalex.org/I4210165485"]},{"raw_affiliation_string":"^Columbus Oncology Associates, Columbus,","institution_ids":["https://openalex.org/I4210094388"]},{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA","institution_ids":["https://openalex.org/I4210150882"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031146012","display_name":"Leslie Rogers Laufman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094388","display_name":"Columbus Oncology and Hematology Associates","ror":"https://ror.org/00qj38h30","country_code":"US","type":"other","lineage":["https://openalex.org/I4210094388"]},{"id":"https://openalex.org/I4210150882","display_name":"Hematology Oncology Consultants","ror":"https://ror.org/04qqn5v91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210150882"]},{"id":"https://openalex.org/I4210165485","display_name":"Columbus Community Clinical Oncology Program","ror":"https://ror.org/05rvv6a54","country_code":"US","type":"other","lineage":["https://openalex.org/I4210165485"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L.R. Laufman","raw_affiliation_strings":["^Columbus Oncology Associates, Columbus,","Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"^Columbus Oncology Associates, Columbus,","institution_ids":["https://openalex.org/I4210094388"]},{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","institution_ids":["https://openalex.org/I4210150882","https://openalex.org/I4210165485"]},{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA","institution_ids":["https://openalex.org/I4210150882"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113044363","display_name":"Louise Carman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094388","display_name":"Columbus Oncology and Hematology Associates","ror":"https://ror.org/00qj38h30","country_code":"US","type":"other","lineage":["https://openalex.org/I4210094388"]},{"id":"https://openalex.org/I4210150882","display_name":"Hematology Oncology Consultants","ror":"https://ror.org/04qqn5v91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210150882"]},{"id":"https://openalex.org/I4210165485","display_name":"Columbus Community Clinical Oncology Program","ror":"https://ror.org/05rvv6a54","country_code":"US","type":"other","lineage":["https://openalex.org/I4210165485"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Carman","raw_affiliation_strings":["Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","^Columbus Oncology Associates, Columbus,","Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","institution_ids":["https://openalex.org/I4210150882","https://openalex.org/I4210165485"]},{"raw_affiliation_string":"^Columbus Oncology Associates, Columbus,","institution_ids":["https://openalex.org/I4210094388"]},{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA","institution_ids":["https://openalex.org/I4210150882"]}]},{"author_position":"middle","author":{"id":null,"display_name":"T. Moore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094388","display_name":"Columbus Oncology and Hematology Associates","ror":"https://ror.org/00qj38h30","country_code":"US","type":"other","lineage":["https://openalex.org/I4210094388"]},{"id":"https://openalex.org/I4210150882","display_name":"Hematology Oncology Consultants","ror":"https://ror.org/04qqn5v91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210150882"]},{"id":"https://openalex.org/I4210165485","display_name":"Columbus Community Clinical Oncology Program","ror":"https://ror.org/05rvv6a54","country_code":"US","type":"other","lineage":["https://openalex.org/I4210165485"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Moore","raw_affiliation_strings":["Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","^Columbus Oncology Associates, Columbus,","Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","institution_ids":["https://openalex.org/I4210150882","https://openalex.org/I4210165485"]},{"raw_affiliation_string":"^Columbus Oncology Associates, Columbus,","institution_ids":["https://openalex.org/I4210094388"]},{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA","institution_ids":["https://openalex.org/I4210150882"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045290402","display_name":"Scott C. Blair","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094388","display_name":"Columbus Oncology and Hematology Associates","ror":"https://ror.org/00qj38h30","country_code":"US","type":"other","lineage":["https://openalex.org/I4210094388"]},{"id":"https://openalex.org/I4210150882","display_name":"Hematology Oncology Consultants","ror":"https://ror.org/04qqn5v91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210150882"]},{"id":"https://openalex.org/I4210165485","display_name":"Columbus Community Clinical Oncology Program","ror":"https://ror.org/05rvv6a54","country_code":"US","type":"other","lineage":["https://openalex.org/I4210165485"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Blair","raw_affiliation_strings":["Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","^Columbus Oncology Associates, Columbus,","Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","institution_ids":["https://openalex.org/I4210150882","https://openalex.org/I4210165485"]},{"raw_affiliation_string":"^Columbus Oncology Associates, Columbus,","institution_ids":["https://openalex.org/I4210094388"]},{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA","institution_ids":["https://openalex.org/I4210150882"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074979472","display_name":"J. B. Jones","orcid":"https://orcid.org/0000-0002-0773-2007","observed_orcids":["https://orcid.org/0000-0002-0773-2007"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Jones","raw_affiliation_strings":["Licking Memorial Hospital Professional Corporation, Newark,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Licking Memorial Hospital Professional Corporation, Newark,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064884330","display_name":"C. P. George","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094388","display_name":"Columbus Oncology and Hematology Associates","ror":"https://ror.org/00qj38h30","country_code":"US","type":"other","lineage":["https://openalex.org/I4210094388"]},{"id":"https://openalex.org/I4210150882","display_name":"Hematology Oncology Consultants","ror":"https://ror.org/04qqn5v91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210150882"]},{"id":"https://openalex.org/I4210165485","display_name":"Columbus Community Clinical Oncology Program","ror":"https://ror.org/05rvv6a54","country_code":"US","type":"other","lineage":["https://openalex.org/I4210165485"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ch. George","raw_affiliation_strings":["Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","^Columbus Oncology Associates, Columbus,","Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","institution_ids":["https://openalex.org/I4210150882","https://openalex.org/I4210165485"]},{"raw_affiliation_string":"^Columbus Oncology Associates, Columbus,","institution_ids":["https://openalex.org/I4210094388"]},{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA","institution_ids":["https://openalex.org/I4210150882"]}]},{"author_position":"middle","author":{"id":null,"display_name":"T. Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094388","display_name":"Columbus Oncology and Hematology Associates","ror":"https://ror.org/00qj38h30","country_code":"US","type":"other","lineage":["https://openalex.org/I4210094388"]},{"id":"https://openalex.org/I4210150882","display_name":"Hematology Oncology Consultants","ror":"https://ror.org/04qqn5v91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210150882"]},{"id":"https://openalex.org/I4210165485","display_name":"Columbus Community Clinical Oncology Program","ror":"https://ror.org/05rvv6a54","country_code":"US","type":"other","lineage":["https://openalex.org/I4210165485"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Patel","raw_affiliation_strings":["^Columbus Oncology Associates, Columbus,","Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"^Columbus Oncology Associates, Columbus,","institution_ids":["https://openalex.org/I4210094388"]},{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","institution_ids":["https://openalex.org/I4210150882","https://openalex.org/I4210165485"]},{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA","institution_ids":["https://openalex.org/I4210150882"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042177713","display_name":"Ralph W. Roach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094388","display_name":"Columbus Oncology and Hematology Associates","ror":"https://ror.org/00qj38h30","country_code":"US","type":"other","lineage":["https://openalex.org/I4210094388"]},{"id":"https://openalex.org/I4210150882","display_name":"Hematology Oncology Consultants","ror":"https://ror.org/04qqn5v91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210150882"]},{"id":"https://openalex.org/I4210165485","display_name":"Columbus Community Clinical Oncology Program","ror":"https://ror.org/05rvv6a54","country_code":"US","type":"other","lineage":["https://openalex.org/I4210165485"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Roach","raw_affiliation_strings":["^Columbus Oncology Associates, Columbus,","Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"^Columbus Oncology Associates, Columbus,","institution_ids":["https://openalex.org/I4210094388"]},{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","institution_ids":["https://openalex.org/I4210150882","https://openalex.org/I4210165485"]},{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA","institution_ids":["https://openalex.org/I4210150882"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110672457","display_name":"R. Rupert","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Rupert","raw_affiliation_strings":["Umversity Hospitals East. Columbus, Ohio, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Umversity Hospitals East. Columbus, Ohio, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054558215","display_name":"Jeffrey Zangmeister","orcid":"https://orcid.org/0000-0001-7202-7438","observed_orcids":["https://orcid.org/0000-0001-7202-7438"]},"institutions":[{"id":"https://openalex.org/I4210094388","display_name":"Columbus Oncology and Hematology Associates","ror":"https://ror.org/00qj38h30","country_code":"US","type":"other","lineage":["https://openalex.org/I4210094388"]},{"id":"https://openalex.org/I4210150882","display_name":"Hematology Oncology Consultants","ror":"https://ror.org/04qqn5v91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210150882"]},{"id":"https://openalex.org/I4210165485","display_name":"Columbus Community Clinical Oncology Program","ror":"https://ror.org/05rvv6a54","country_code":"US","type":"other","lineage":["https://openalex.org/I4210165485"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Zangmeister","raw_affiliation_strings":["Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","^Columbus Oncology Associates, Columbus,","Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","institution_ids":["https://openalex.org/I4210150882","https://openalex.org/I4210165485"]},{"raw_affiliation_string":"^Columbus Oncology Associates, Columbus,","institution_ids":["https://openalex.org/I4210094388"]},{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA","institution_ids":["https://openalex.org/I4210150882"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080518829","display_name":"Dave Colborn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094388","display_name":"Columbus Oncology and Hematology Associates","ror":"https://ror.org/00qj38h30","country_code":"US","type":"other","lineage":["https://openalex.org/I4210094388"]},{"id":"https://openalex.org/I4210150882","display_name":"Hematology Oncology Consultants","ror":"https://ror.org/04qqn5v91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210150882"]},{"id":"https://openalex.org/I4210165485","display_name":"Columbus Community Clinical Oncology Program","ror":"https://ror.org/05rvv6a54","country_code":"US","type":"other","lineage":["https://openalex.org/I4210165485"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Colborn","raw_affiliation_strings":["Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","^Columbus Oncology Associates, Columbus,","Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","institution_ids":["https://openalex.org/I4210150882","https://openalex.org/I4210165485"]},{"raw_affiliation_string":"^Columbus Oncology Associates, Columbus,","institution_ids":["https://openalex.org/I4210094388"]},{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA","institution_ids":["https://openalex.org/I4210150882"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109259383","display_name":"J. Philip Kuebler","orcid":"https://orcid.org/0009-0004-0964-2971","observed_orcids":["https://orcid.org/0009-0004-0964-2971"]},"institutions":[{"id":"https://openalex.org/I4210094388","display_name":"Columbus Oncology and Hematology Associates","ror":"https://ror.org/00qj38h30","country_code":"US","type":"other","lineage":["https://openalex.org/I4210094388"]},{"id":"https://openalex.org/I4210150882","display_name":"Hematology Oncology Consultants","ror":"https://ror.org/04qqn5v91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210150882"]},{"id":"https://openalex.org/I4210165485","display_name":"Columbus Community Clinical Oncology Program","ror":"https://ror.org/05rvv6a54","country_code":"US","type":"other","lineage":["https://openalex.org/I4210165485"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.Ph. Kuebler","raw_affiliation_strings":["Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","^Columbus Oncology Associates, Columbus,","Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated, ^Columbus Community Clinical Oncology Program. ' Mid-Ohio Oncologv Group,","institution_ids":["https://openalex.org/I4210150882","https://openalex.org/I4210165485"]},{"raw_affiliation_string":"^Columbus Oncology Associates, Columbus,","institution_ids":["https://openalex.org/I4210094388"]},{"raw_affiliation_string":"Hematology Oncology Consultants Incorporated 393 East Town Street, Suite 109 Columbus, OH 43215 USA","institution_ids":["https://openalex.org/I4210150882"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":5.8526,"has_fulltext":true,"cited_by_count":43,"citation_normalized_percentile":{"value":0.9621097,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"12","issue":"1","first_page":"89","last_page":"94"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0215000007301569,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9900000095367432},{"id":"https://openalex.org/keywords/second-line-chemotherapy","display_name":"second-line chemotherapy","score":0.9800000190734863},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9890000224113464},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7070000171661377},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.7149999737739563},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9440000057220459},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.8569999933242798},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.42899999022483826}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9414318799972534},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.93785160779953},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.9130529165267944},{"id":"https://openalex.org/C2780350996","wikidata":"https://www.wikidata.org/wiki/Q420532","display_name":"Vinorelbine","level":4,"score":0.7835378646850586},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7201088666915894},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6897757649421692},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.6583477854728699},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5905813574790955},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5872562527656555},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5285096764564514},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5097333788871765},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.4806212782859802},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.4498823285102844},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.44098782539367676},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.36761540174484253},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.36420896649360657},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.09419870376586914}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1023/a:1008306616994","doi":"https://doi.org/10.1023/a:1008306616994","is_oa":true,"landing_page_url":"https://doi.org/10.1023/a:1008306616994","pdf_url":"https://doi.org/10.1023/a:1008306616994","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},{"id":"pmid:11249055","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11249055","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of oncology : official journal of the European Society for Medical Oncology","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1023/a:1008306616994","doi":"https://doi.org/10.1023/a:1008306616994","is_oa":true,"landing_page_url":"https://doi.org/10.1023/a:1008306616994","pdf_url":"https://doi.org/10.1023/a:1008306616994","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8500000238418579}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2168653455.pdf","grobid_xml":"https://content.openalex.org/works/W2168653455.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W1837121308","https://openalex.org/W1839238860","https://openalex.org/W1848316250","https://openalex.org/W1865725105","https://openalex.org/W1868450210","https://openalex.org/W1883066466","https://openalex.org/W1890647543","https://openalex.org/W1911047310","https://openalex.org/W1933707312","https://openalex.org/W1979300931","https://openalex.org/W1984254136","https://openalex.org/W2044678785","https://openalex.org/W2045537207","https://openalex.org/W2089062211","https://openalex.org/W2113574953","https://openalex.org/W2130652363","https://openalex.org/W2161731922","https://openalex.org/W2177569300","https://openalex.org/W2235063564","https://openalex.org/W2425282278","https://openalex.org/W4293241248"],"related_works":["https://openalex.org/W2003291927","https://openalex.org/W1973241390","https://openalex.org/W2043119894","https://openalex.org/W1978467028","https://openalex.org/W2315587357","https://openalex.org/W1987606751","https://openalex.org/W2080820783","https://openalex.org/W1598707215","https://openalex.org/W7095256817","https://openalex.org/W2301445491"],"abstract_inverted_index":null,"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}